We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Caribou Biosciences Inc | NASDAQ:CRBU | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.14 | -7.95% | 1.62 | 1.62 | 1.63 | 1.79 | 1.615 | 1.77 | 1,522,498 | 20:46:49 |
From Jun 2023 to Jun 2024
10:14 ET -- Caribou Biosciences is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The clinical-stage biopharmaceutical company received a $25 million equity investment from drug giant Pfizer at a 31% premium, sending its shares up nearly 60%. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
July 06, 2023 10:29 ET (14:29 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Caribou Biosciences Chart |
1 Month Caribou Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
